Factor XI/XIa inhibitors versus direct oral anticoagulants in atrial fibrillation with stroke risk: a GRADE-assessed meta-analysis of randomized controlled trials.

abelacimab (MAA868) - Novartis

asundexian (BAY 2433334) - Bayer

http://www.ncbi.nlm.nih.gov/pubmed/40377680

Ahmed Abduljalil Mohammed; Ahmed Emara; Ahmed Farid Gadelmawla; Basel Abdelazeem; Lina Hemmeda; Mohamed A Aldemerdash; Mohamed Ellebedy; Mohamed Emara; Mohamed R Murad; Mohamed S Elgendy

May 16, 2025